Your browser doesn't support javascript.
loading
Natural history of TANGO2 deficiency disorder: Baseline assessment of 73 patients.
Miyake, Christina Y; Lay, Erica J; Soler-Alfonso, Claudia; Glinton, Kevin E; Houck, Kimberly M; Tosur, Mustafa; Moran, Nancy E; Stephens, Sara B; Scaglia, Fernando; Howard, Taylor S; Kim, Jeffrey J; Pham, Tam Dam; Valdes, Santiago O; Li, Na; Murali, Chaya N; Zhang, Lilei; Kava, Maina; Yim, Deane; Beach, Cheyenne; Webster, Gregory; Liberman, Leonardo; Janson, Christopher M; Kannankeril, Prince J; Baxter, Samantha; Singer-Berk, Moriel; Wood, Jordan; Mackenzie, Samuel J; Sacher, Michael; Ghaloul-Gonzalez, Lina; Pedroza, Claudia; Morris, Shaine A; Ehsan, Saad A; Azamian, Mahshid S; Lalani, Seema R.
Affiliation
  • Miyake CY; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX. Electronic address: cymiyake@bcm.edu.
  • Lay EJ; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Soler-Alfonso C; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Glinton KE; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Houck KM; Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Tosur M; Division of Diabetes and Endocrinology, Department of Pediatrics, USDA/ARS Children's Nutrition Research Center, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Moran NE; USDA/ARS Children's Nutrition Research Center, Division of Nutrition, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Stephens SB; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Scaglia F; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX; BCM-CUHK Center of Medical Genetics, Prince of Wales Hospital, Hong Kong, Special Administrative Region.
  • Howard TS; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Kim JJ; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Pham TD; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Valdes SO; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Li N; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX; Department of Medicine, Section of Cardiovascular Research, Baylor College of Medicine, Houston, TX.
  • Murali CN; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Zhang L; Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston TX; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Kava M; Department of Neurology, Perth Children's Hospital, Perth, Western Australia, Australia; Departments of Metabolic Medicine and Rheumatology, Perth Children's Hospital, Perth, Western Australia, Australia; Medical School, University of Western Australia, Perth, Western Australia, Australia.
  • Yim D; Department of Cardiology, Perth Children's Hospital, Perth, Western Australia, Australia.
  • Beach C; Division of Cardiology, Department of Pediatrics, Yale School of Medicine, Yale University, New Haven, CT.
  • Webster G; Division of Cardiology, Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Nortwestern University Feinberg School of Medicine, Chicago, IL.
  • Liberman L; Division of Cardiology, Department of Pediatrics, New York Presbyterian Morgan Stanley Children's Hospital, New York, NY.
  • Janson CM; Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA.
  • Kannankeril PJ; Center for Pediatric Precision Medicine, Department of Pediatrics, Vanderbilt University Medical Center and the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, TN.
  • Baxter S; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Singer-Berk M; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Wood J; Broad Institute of MIT and Harvard, Cambridge, MA.
  • Mackenzie SJ; Department of Neurology, University of Rochester Medical Center, Rochester, NY.
  • Sacher M; Department of Biology, Concordia University, Montreal, Quebec, Canada; Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada.
  • Ghaloul-Gonzalez L; Division of Genetic and Genomic Medicine, Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA.
  • Pedroza C; Department of Pediatrics, McGovern Medical School, University of Texas Health Center at Houston, Houston, TX.
  • Morris SA; Division of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
  • Ehsan SA; Baylor College of Medicine, Houston, TX.
  • Azamian MS; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
  • Lalani SR; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Genet Med ; 25(4): 100352, 2023 04.
Article in En | MEDLINE | ID: mdl-36473599
ABSTRACT

PURPOSE:

TANGO2 deficiency disorder (TDD), an autosomal recessive disease first reported in 2016, is characterized by neurodevelopmental delay, seizures, intermittent ataxia, hypothyroidism, and life-threatening metabolic and cardiac crises. The purpose of this study was to define the natural history of TDD.

METHODS:

Data were collected from an ongoing natural history study of patients with TDD enrolled between February 2019 and May 2022. Data were obtained through phone or video based parent interviews and medical record review.

RESULTS:

Data were collected from 73 patients (59% male) from 57 unrelated families living in 16 different countries. The median age of participants at the time of data collection was 9.0 years (interquartile range = 5.3-15.9 years, range = fetal to 31.8 years). A total of 24 different TANGO2 alleles were observed. Patients showed normal development in early infancy, with progressive delay in developmental milestones thereafter. Symptoms included ataxia, dystonia, and speech difficulties, typically starting between the ages of 1 to 3 years. A total of 46/71 (65%) patients suffered metabolic crises, and of those, 30 (65%) developed cardiac crises. Metabolic crises were significantly decreased after the initiation of B-complex or multivitamin supplementation.

CONCLUSION:

We provide the most comprehensive review of natural history of TDD and important observational data suggesting that B-complex or multivitamins may prevent metabolic crises.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ataxia / Seizures Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Pregnancy Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ataxia / Seizures Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Pregnancy Language: En Journal: Genet Med Journal subject: GENETICA MEDICA Year: 2023 Type: Article